Terefe Ermias Mergia, Okalebo Faith Apolot, Derese Solomon, Muriuki Joseph, Batiha Gaber El-Saber
Department of Pharmacology and Pharmacognosy, United States International University-Africa, Nairobi, Kenya.
Department of Pharmacology and Pharmacognosy, University of Nairobi, Nairobi, Kenya.
J Exp Pharmacol. 2021 Dec 22;13:971-979. doi: 10.2147/JEP.S335104. eCollection 2021.
Human immunodeficiency virus (HIV) affects the body's defense mechanisms and leads to a number of opportunistic infections which later cause fatality as a result of an acquired immunodeficiency syndrome (AIDS). More than half a million individuals have lost their life in 2020 due to this disease. Antiretroviral drugs have played a great role in improving the quality of life of HIV infected individuals. The side effects of these drugs coupled with resistance of the virus to the various regimens, necessitates the search for potentially new and effective antiretroviral medication. The objective of this study is to evaluate anti-HIV activity of crude extracts of three plants.
As part of our effort in screening anti-HIV medications, we evaluated the cytotoxicity and anti-HIV activity of three species used as herbal medicine in Africa. Crude extracts of and were tested for their replication inhibition activity against laboratory adapted strains HIV-1 in Human T-lymphocytic MT-4 cell line.
Based on our findings, the crude aerial part extract of displayed the highest anti-HIV activity by inhibiting 73.74% of viral induced cytopathic effect (CPE) at IC value of 0.001 + 0.00 μg/mL giving a selectivity index (SI) of 3116.0. In addition, the crude leaf extract of showed higher anti-HIV activity by inhibiting 74.65% of CPE at IC value of 0.05 + 0.03 μg/mL giving an SI of 571.3.
Out of five extracts from three species screened for anti-HIV activity using human T-lymphocytic MT-4 cells, the leaf extract of and aerial part extract of could be considered as promising extracts as they display high antiviral activity with low toxicity and high selectivity index values. To investigate the active constituents responsible for the anti-HIV activity, chemical identification of the active constituents is now in progress in our laboratory. Since there is no previously reported anti-HIV activity for these plants, there is a great need to isolate the compounds responsible for the noted activity.
人类免疫缺陷病毒(HIV)会影响人体的防御机制,并导致多种机会性感染,这些感染随后会因获得性免疫缺陷综合征(AIDS)而导致死亡。2020年,超过50万人死于这种疾病。抗逆转录病毒药物在改善HIV感染者的生活质量方面发挥了重要作用。这些药物的副作用以及病毒对各种治疗方案的耐药性,使得有必要寻找潜在的新型有效抗逆转录病毒药物。本研究的目的是评估三种植物粗提物的抗HIV活性。
作为我们筛选抗HIV药物工作的一部分,我们评估了非洲用作草药的三种植物的细胞毒性和抗HIV活性。测试了[植物名称1]和[植物名称2]的粗提物对人T淋巴细胞MT-4细胞系中实验室适应株HIV-1的复制抑制活性。
根据我们的研究结果,[植物名称1]的地上部分粗提物表现出最高的抗HIV活性,在IC值为0.001±0.00μg/mL时抑制73.74%的病毒诱导细胞病变效应(CPE),选择性指数(SI)为3116.0。此外,[植物名称2]的叶粗提物在IC值为0.05±0.03μg/mL时抑制74.65%的CPE,表现出较高的抗HIV活性,SI为571.3。
在使用人T淋巴细胞MT-4细胞筛选抗HIV活性的三种植物的五种提取物中,[植物名称2]的叶提取物和[植物名称1]的地上部分提取物可被视为有前景的提取物,因为它们表现出高抗病毒活性、低毒性和高选择性指数值。为了研究负责抗HIV活性的活性成分,我们实验室正在对活性成分进行化学鉴定。由于此前没有关于这些植物抗HIV活性的报道,非常需要分离出具有所述活性的化合物。